StockData
Cognition Therapeutics Inc logo

Cognition Therapeutics Inc (CGTX) stock

CGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.63−0.01 (-1.39%)

Close on Nov 17, 2026Market cap $59.90MP/E –Yield –

Earnings

Cognition Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 25, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.04
-$0.06 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Cognition Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 25, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026before the open––-$0.04Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026during market hours––-$0.04Release
Q1 FY2026ended Mar 31, 2026May 7, 2026during market hours––-$0.05Release
Q4 FY2025ended Dec 31, 2025Mar 26, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025before the open––-$0.06Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025during market hours––-$0.11Release
Q1 FY2025ended Mar 31, 2025May 7, 2025before the open––-$0.14Release
Q4 FY2024ended Dec 31, 2024Mar 20, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024before the open––-$0.25Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024before the open––-$0.18Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open––-$0.27Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Cognition Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Cognition Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Cognition Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. Results
  4. News
  5. Update
  6. News
  7. Results
  8. Results
  9. Results
  10. News
  11. News
  12. Results
  13. News
  14. Results
  15. News

See a number that looks wrong?